Navigation Links
German National Academy of Sciences issues a critical statement on the use of bioenergy
Date:7/26/2012

In a statement on the chances and limits of using bioenergy, the German National Academy of Sciences Leopoldina has come to the conclusion that in quantitative terms, bioenergy plays a minor role in the transition to renewable, sustainable energy sources in Germany at the present time and probably in the future. Bioenergy requires more surface area, is associated with higher greenhouse gas emissions and is more harmful to the environment than other renewable sources such as photovoltaic, solar thermal energy and wind energy. In addition, energy crops potentially compete with food crops. The report recommends finding strategies for saving energy and increasing energy efficiency.

The Leopoldina's statement "Bioenergy Chances and Limits" was compiled by a working group of more than 20 expert scientists established in 2010. The report provides recommendations for using bioenergy, defined as energy obtained from burning of non-fossil plant biomass or biofuels derived primarily from biomass.

The statement also outlines under which conditions the utilization of bioenergy is appropriate and what kind of technologies are currently available or are being developed to convert biomass into biofuels such as bioethanol and biodiesel. In addition, it introduces various scientific approaches aimed at producing hydrogen from water in a sustainable and environmentally friendly manner.


'/>"/>
Contact: Caroline Wichmann
presse@leopoldina.org
0049-345-472-39800
Leopoldina
Source:Eurekalert

Page: 1

Related biology news :

1. Copernicus Award 2012 for German-Polish collaboration in business information systems
2. Story tips From the Department of Energys Oak Ridge National Laboratory, March 2012
3. Ultracold matter technology from CU and SRI International licensed to Boulders ColdQuanta
4. International Polar Year conference: From knowledge to action
5. ASBMB wins National Science Foundation grant to enhance K-12 science education
6. President, CEO Leppävuori, VTT: Finland should create a national bioeconomy strategy
7. Russia declares Land of the Leopard National Park
8. Large international study finds memory in adults impacted by versions of 4 genes
9. International team uncovers new genes that shape brain size, intelligence
10. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
11. Southampton researchers lead 2 international projects to help people out of poverty
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... 20, 2017 At this year,s CeBIT Chancellor Dr. ... manufacturer DERMALOG. The Chancellor came to the DERMALOG stand together with the ... year,s CeBIT partner country. At the largest German biometrics company the two ... face and iris recognition as well as DERMALOGĀ“s multi-biometrics system.   ... ...
(Date:3/16/2017)... -- CeBIT 2017 - Against identity fraud with DERMALOG solutions "Made in ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against identity fraud. (PRNewsFoto/Dermalog ... Used combined in one project, multi-biometric solutions provide ... ...
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed ... both viscous and elastic characteristics when deformed, which is identical to how the ... gently absorb compressive forces and return to its natural state along a hysteresis ...
(Date:3/23/2017)... March 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) ... immune therapies for solid tumor cancers, today announced ... financing it announced last Friday, March 17, 2017. ... institutional investors securities totaling 28,843,692 shares, comprised of ... 10,000,000 shares of Class C Warrants pre-funded at ...
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... YORK , March 23, 2017 ... ... of death, putting significant strain on health care systems, in ... cancer diagnoses rises, so too does the development of innovative ... minimum side effects. Among the many types of cancer treatments, ...
Breaking Biology Technology: